URINARY TRACT
ANTI-INFECTIVE
AGENTS
BY
KENCHA SWATHI
ASSISTANT PROFESSOR
Swathi Pharma Jnan
URINARY TRACT ANTI-INFECTIVE
AGENTS
Definition: Antibacterial agents that fail to achieve adequate concentrations in
the plasma or tissues for the treatment of systemic infections following oral or
parentral administration are concentrated in the urine,where they can be
effective for eradicating urinary tract infections.
Swathi Pharma Jnan
CLASSIFICATION
Based on chemical structure:
1.Quinolone derivatives – Nalidixic acid,Norfloxacin,Ciprofloxacin
2.Nitrofuran derivatives – Nitrofurantoin
3.Methenamine and its salts – Hexamine(Hexa methylene Tetramine)
4.Urinary analgesics – Phenyl azo pyridine
Swathi Pharma Jnan
QUINOLONE DERIVATIVES
• These are isosteric heterocyclic groupings which includes –
a.Quinolones –Norfloxacin
Ciprofloxacin,Sparfloxacin,Lomefloxacin,O-floxacin
b.Naphthyridines(1,8-Napthyridines) – Nalidixic acid,Enoxacin
c.Cinnolines(1,2-Napthyridines) – Cinnoxacin
Quinolone derivatives contain isosteric substitution of carbon by nitrogen.
Swathi Pharma Jnan
SAR OF QUINOLONES
• 1,4-dihydro 4-oxo pyridine 3-carboxylic acid is essential for anti-bacterial
activity.
• Pyridone should be fused with aromatic ring for showing activity.
Swathi Pharma Jnan
• Isosteric replacements of nitrogen for carbon atoms at position
2(cinnolines),position 5(1,5-naphthyridines),position 6(1,6-
naphthyridines),position 8(1,8-naphthyridines) are consistent with retained
antibacterial activity.
• 1,7-naphthyridines and 1,3-naphthyridines are not active.
• 1,2-Naphthyridines(Cinnolines) are showing better activity.
Eg:
Swathi Pharma Jnan
• 1,5-naphthyridines have isosteric substitution of carbon with nitrogen at 5th
position.
Eg:
• 1,8-Naphthyridines shows better activity compared to other napthyridines.
Eg: Nalidixic acid
Swathi Pharma Jnan
• Introduction of substituents at position 2 greatly abolishes the activity.
• Introduction of substituents at position 5,6,7 (especially at 8) of anneulated ring
will result in compounds with good activity.
• Normally at 7th position piperazinyl (saturated pyrazine)structure is common.
• 3-Amino pyrrolidinyl(saturated pyrrole) substituents at position 7 enhances the
activity of quinolone class against “Pseudomonas aerogenosa”.
Eg: Enoxacin
Swathi Pharma Jnan
• F atom substitution at position 6 also significantly enhances the antibacterial
activity.
• Alkyl substitution at position 1 is essential for activity with lower alkyl groups like
methyl,ethyl,cyclopropyl group containing compounds have progressively greater
potency.
Eg:Ciprofloxacin
Swathi Pharma Jnan
• If we have aryl substitution at position 1 is also consisting with the antibacterial
activity with 2,4-difluorogroups produces optimum activity.
• Ring condensation compounds are active
Eg: Cinnoxacin - 6,7-fusion & O-Floxacin -1,8 condensation
Swathi Pharma Jnan
• 6-Fluoro quinolones having basic moieties like 1-piperidino-3-amino,1-pyrrolidino or
similar basic moiety at the 7th position will have some CNS effects such as
irritability,tremors,sleep disorders,vertigo,anxiety,agitation and convulsions etc.,
Eg: O-Floxacin
• Quinolones possessing additional halogen atom at 8th position shows along with
CNS effects they also exihibit phototoxicity.
• One more F at 8th position causes sensitive towards photolight.
Eg: Lomefloxacin
Swathi Pharma Jnan
• Quinolone derivatives having an amino group or methoxy group either at 5th or 8th
position will have lowest incidence of photo light.
Eg: Sparfloxacin
Swathi Pharma Jnan
NORFLOXACIN
USES: In the treatment of UTI’s caused by E.Coli,Pneumonia,Enterobacter
species,Proteus species and staphylococcus aureus.
Swathi Pharma Jnan
SPARFLOXACIN
USES: To treat skin and soft tissue infections.
To treat lower respiratory tract infetions like bronchitis and bacterial
pneumonia,pelvic inflammatory disease caused by gonorrhoea,chlamydia
species.
Swathi Pharma Jnan
CIPROFLOXACIN
Swathi Pharma Jnan
USES: To treat bacterial gastroenteritis caused by gram –ve bacteria .
It is widely used for the treatment of respiratory tract infections such as pneumonia
caused by gram –ve bacteria.
To treat UTI ,venereal disease. For post exposure treatment of inhalation anthrax.
LOMEFLOXACIN
USES: To treat Urinary tract infections
Swathi Pharma Jnan
O-FLOXACIN
USES: To treat lower respiratory tract infections and pelvic inflammatory
disease.
To treat UTI’s caused by gram-ve bacteria and for prostatitis caused by
E.Coli.
To treat soft tissue /skin infections caused by staphylococcus,streptococci .Swathi Pharma Jnan
NALIDIXIC ACID
USES:In the treatment of UTI’s in which gram –ve bacteria predominates.
Swathi Pharma Jnan
ENOXACIN
USES: To treat urinary tract infections
Swathi Pharma Jnan
CINNOXACIN
USES: To treat UTI infection in which gram-ve bacteria is susceptible .
Swathi Pharma Jnan
NITROFURANTOIN
USES: To treat bacterial infections.
Antiprotozoal drug
Swathi Pharma Jnan
METHENAMINE(HEXAMETHYLENE
TETRAMINE)
Uses: Used as urinary antiseptic and for the treatment of chronic UTI’s.
Swathi Pharma Jnan
PHENYL AZO PYRIDINE
USES: Used as local analgesic which acts on the mucosa of urinary tract.
Swathi Pharma Jnan
MOA OF QUINOLONES
• Quinolones produces their antibacterial activity by inhibiting the synthesis of
DNA due to the inhibition of bacterial DNA gyrase(topoisomerase-2),an
enzyme responsible for introducing negative supercoils into circular duplex
DNA.
• Negative supercoiling relieves torsional stress of unwinding helical DNA and
there by allows transcription and replication to occur .
Swathi Pharma Jnan
MOA OF NITROFURANTOIN
Swathi Pharma Jnan
SYNTHESIS OF NITROFURANTOIN
Swathi Pharma Jnan
5-Nitrofurfural 1-Amino
hydantoin Nitrofurantoin
NaOH
-H₂O

UTI Agents

  • 1.
  • 2.
    URINARY TRACT ANTI-INFECTIVE AGENTS Definition:Antibacterial agents that fail to achieve adequate concentrations in the plasma or tissues for the treatment of systemic infections following oral or parentral administration are concentrated in the urine,where they can be effective for eradicating urinary tract infections. Swathi Pharma Jnan
  • 3.
    CLASSIFICATION Based on chemicalstructure: 1.Quinolone derivatives – Nalidixic acid,Norfloxacin,Ciprofloxacin 2.Nitrofuran derivatives – Nitrofurantoin 3.Methenamine and its salts – Hexamine(Hexa methylene Tetramine) 4.Urinary analgesics – Phenyl azo pyridine Swathi Pharma Jnan
  • 4.
    QUINOLONE DERIVATIVES • Theseare isosteric heterocyclic groupings which includes – a.Quinolones –Norfloxacin Ciprofloxacin,Sparfloxacin,Lomefloxacin,O-floxacin b.Naphthyridines(1,8-Napthyridines) – Nalidixic acid,Enoxacin c.Cinnolines(1,2-Napthyridines) – Cinnoxacin Quinolone derivatives contain isosteric substitution of carbon by nitrogen. Swathi Pharma Jnan
  • 5.
    SAR OF QUINOLONES •1,4-dihydro 4-oxo pyridine 3-carboxylic acid is essential for anti-bacterial activity. • Pyridone should be fused with aromatic ring for showing activity. Swathi Pharma Jnan
  • 6.
    • Isosteric replacementsof nitrogen for carbon atoms at position 2(cinnolines),position 5(1,5-naphthyridines),position 6(1,6- naphthyridines),position 8(1,8-naphthyridines) are consistent with retained antibacterial activity. • 1,7-naphthyridines and 1,3-naphthyridines are not active. • 1,2-Naphthyridines(Cinnolines) are showing better activity. Eg: Swathi Pharma Jnan
  • 7.
    • 1,5-naphthyridines haveisosteric substitution of carbon with nitrogen at 5th position. Eg: • 1,8-Naphthyridines shows better activity compared to other napthyridines. Eg: Nalidixic acid Swathi Pharma Jnan
  • 8.
    • Introduction ofsubstituents at position 2 greatly abolishes the activity. • Introduction of substituents at position 5,6,7 (especially at 8) of anneulated ring will result in compounds with good activity. • Normally at 7th position piperazinyl (saturated pyrazine)structure is common. • 3-Amino pyrrolidinyl(saturated pyrrole) substituents at position 7 enhances the activity of quinolone class against “Pseudomonas aerogenosa”. Eg: Enoxacin Swathi Pharma Jnan
  • 9.
    • F atomsubstitution at position 6 also significantly enhances the antibacterial activity. • Alkyl substitution at position 1 is essential for activity with lower alkyl groups like methyl,ethyl,cyclopropyl group containing compounds have progressively greater potency. Eg:Ciprofloxacin Swathi Pharma Jnan
  • 10.
    • If wehave aryl substitution at position 1 is also consisting with the antibacterial activity with 2,4-difluorogroups produces optimum activity. • Ring condensation compounds are active Eg: Cinnoxacin - 6,7-fusion & O-Floxacin -1,8 condensation Swathi Pharma Jnan
  • 11.
    • 6-Fluoro quinoloneshaving basic moieties like 1-piperidino-3-amino,1-pyrrolidino or similar basic moiety at the 7th position will have some CNS effects such as irritability,tremors,sleep disorders,vertigo,anxiety,agitation and convulsions etc., Eg: O-Floxacin • Quinolones possessing additional halogen atom at 8th position shows along with CNS effects they also exihibit phototoxicity. • One more F at 8th position causes sensitive towards photolight. Eg: Lomefloxacin Swathi Pharma Jnan
  • 12.
    • Quinolone derivativeshaving an amino group or methoxy group either at 5th or 8th position will have lowest incidence of photo light. Eg: Sparfloxacin Swathi Pharma Jnan
  • 13.
    NORFLOXACIN USES: In thetreatment of UTI’s caused by E.Coli,Pneumonia,Enterobacter species,Proteus species and staphylococcus aureus. Swathi Pharma Jnan
  • 14.
    SPARFLOXACIN USES: To treatskin and soft tissue infections. To treat lower respiratory tract infetions like bronchitis and bacterial pneumonia,pelvic inflammatory disease caused by gonorrhoea,chlamydia species. Swathi Pharma Jnan
  • 15.
    CIPROFLOXACIN Swathi Pharma Jnan USES:To treat bacterial gastroenteritis caused by gram –ve bacteria . It is widely used for the treatment of respiratory tract infections such as pneumonia caused by gram –ve bacteria. To treat UTI ,venereal disease. For post exposure treatment of inhalation anthrax.
  • 16.
    LOMEFLOXACIN USES: To treatUrinary tract infections Swathi Pharma Jnan
  • 17.
    O-FLOXACIN USES: To treatlower respiratory tract infections and pelvic inflammatory disease. To treat UTI’s caused by gram-ve bacteria and for prostatitis caused by E.Coli. To treat soft tissue /skin infections caused by staphylococcus,streptococci .Swathi Pharma Jnan
  • 18.
    NALIDIXIC ACID USES:In thetreatment of UTI’s in which gram –ve bacteria predominates. Swathi Pharma Jnan
  • 19.
    ENOXACIN USES: To treaturinary tract infections Swathi Pharma Jnan
  • 20.
    CINNOXACIN USES: To treatUTI infection in which gram-ve bacteria is susceptible . Swathi Pharma Jnan
  • 21.
    NITROFURANTOIN USES: To treatbacterial infections. Antiprotozoal drug Swathi Pharma Jnan
  • 22.
    METHENAMINE(HEXAMETHYLENE TETRAMINE) Uses: Used asurinary antiseptic and for the treatment of chronic UTI’s. Swathi Pharma Jnan
  • 23.
    PHENYL AZO PYRIDINE USES:Used as local analgesic which acts on the mucosa of urinary tract. Swathi Pharma Jnan
  • 24.
    MOA OF QUINOLONES •Quinolones produces their antibacterial activity by inhibiting the synthesis of DNA due to the inhibition of bacterial DNA gyrase(topoisomerase-2),an enzyme responsible for introducing negative supercoils into circular duplex DNA. • Negative supercoiling relieves torsional stress of unwinding helical DNA and there by allows transcription and replication to occur . Swathi Pharma Jnan
  • 25.
  • 26.
    SYNTHESIS OF NITROFURANTOIN SwathiPharma Jnan 5-Nitrofurfural 1-Amino hydantoin Nitrofurantoin NaOH -H₂O